Using a case-control design, we evaluated differences in risk factors for colorectal polyps according to histological type, anatomical site, and severity. Participants were enrollees in the Group Health Cooperative aged 20-79 years who underwent colonoscopy in Seattle, Washington, between 1998 and 2007 and comprised 628 adenoma cases, 594 serrated polyp cases, 247 cases with both types of polyps, and 1,037 polyp-free controls. Participants completed a structured interview, and polyps were evaluated via standardized pathology review. We used multivariable polytomous logistic regression to compare case groups with controls and with the other case groups. Factors for which the strength of the association varied significantly between adenomas and serrated polyps were sex (P < 0.001), use of estrogen-only postmenopausal hormone therapy (P = 0.01), and smoking status (P < 0.001). For lesion severity, prior endoscopy (P < 0.001) and age (P = 0.05) had significantly stronger associations with advanced adenomas than with nonadvanced adenomas; and higher education was positively correlated with sessile serrated polyps but not with other serrated polyps (P = 0.02). Statistically significant, sitespecific associations were observed for current cigarette smoking (P = 0.05 among adenomas and P < 0.001 among serrated polyps), postmenopausal estrogen-only therapy (P = 0.01 among adenomas), and obesity (P = 0.01 among serrated polyps). These findings further illustrate the epidemiologic heterogeneity of colorectal neoplasia and may help elucidate carcinogenic mechanisms for distinct pathways.
as potential precursors for colorectal cancer (12) (13) (14) . In contrast, other serrated polyps, like hyperplastic polyps, are not dysplastic and previously were considered to have no malignant potential (15) . However, recently, a subset of hyperplastic polyps has been reclassified as SSPs. SSPs have a saw-toothed appearance at the surface and are characterized by a proliferation zone that has moved upwards away from the base of the colonic crypt, basal crypt distortion, altered crypt polarity, and dysmaturational features (16, 17) . Now, consensus is emerging that SSPs may be an "advanced" lesion in the serrated pathway (18, 19) . Because of the potential clinical importance of SSPs, some argue that these newly classified polyps should be referred to as sessile serrated adenomas (18, 19) . However, to avoid confusion and reinforce the fact that these polyps are histologically distinct from conventional adenomas, we use the term SSP.
Previous studies have evaluated risk factors for serrated and adenomatous polyps; although these distinct entities share many risk factors, certain risk factors differ between polyp groups or appear to have stronger associations with one group than with the other (15, (20) (21) (22) (23) (24) . In addition, anatomical subsites within the colon are associated with different cancer risk factors (25) . These differences may provide insight into the unique mechanisms by which cancer initiation occurs at each anatomical site and in each pathway. Despite this, few studies of adenomas and serrated polyps have evaluated risk factors for each polyp group according to anatomical subsite, and only 1 small study of 90 SSPs specifically evaluated risk factors for SSPs (26) . Therefore, we conducted a large case-control study of adenomas, serrated polyps, and polyp-free controls to evaluate differences in risk factors for distinct polyp subtypes.
MATERIALS AND METHODS

Study population
Participants were enrollees in the Group Health Cooperative, an integrated health-care provider in Washington State, aged 20-79 years who underwent an index colonoscopy for any indication between 1998 and 2007 and were diagnosed on the basis of clinical pathology with adenomas (International Classification of Diseases, Ninth Revision (ICD-9), code 211.3) and/or hyperplastic polyps (ICD-9 code 211. 4) or who were polyp-free (controls). Eligible persons had been enrolled in the Group Health Cooperative for at least 3 years and had not undergone a prior colonoscopy within 1 year of the index colonoscopy. Participants with poor bowel preparation at the index colonoscopy and those with a prior or new diagnosis of colorectal cancer, familial colorectal cancer syndromes (such as familial adenomatous polyposis), or other colorectal disease were ineligible. A systematic sample of eligible colonoscopy patients was recruited, and approximately 75% agreed to participate and provided written informed consent. Based on medical records, persons who agreed to participate and those who refused study participation were similar with respect to age, sex, and colorectal polyp status. Study protocols were approved by the institutional review boards of the Group Health Cooperative and the Fred Hutchinson Cancer Research Center (Seattle, Washington). Additional details on the study population have been previously reported (24, (27) (28) (29) (30) .
Study questionnaire
Participants completed a structured questionnaire that elicited information on personal and family medical history, colorectal screening, height, weight, use of nonsteroidal antiinflammatory drugs (NSAIDs), hormone therapy, cigarette smoking, alcohol consumption, and physical activity. Attention was limited to experiences that had occurred at least 1 year before the index colonoscopy. Data collection took place in 2 phases, and similar questionnaires were used in both phases. During phase I, potential participants were identified from a listing of patients undergoing colonoscopy between September 1998 and March 2003 at the Group Health Cooperative gastroenterology clinic in Seattle, and participants were interviewed prior to colonoscopy. During phase II, which included patients receiving colonoscopy between December 2004 and September 2007, study participants were interviewed an average of 3-4 months following the index colonoscopy. Controls were participants who had no colorectal polyps identified during the index colonoscopy and were systematically sampled to reflect the age distribution (within a 5-year range) and calendar year of all polyp cases.
Standardized pathology review
Index colonoscopy biopsies were stored in formalinfixed paraffin-embedded blocks. Sections were cut, placed onto slides, and stained with hematoxylin and eosin. Two study pathologists worked in tandem to conduct a standardized pathology review of polyp tissue slides and to reclassify a subset of polyps as SSPs using established protocols and classification criteria. Disagreements between study pathologists were reconciled through re-review by both pathologists and by referring to a standard training set of polyp slides. If a participant had at least 1 of the following types of polyps and no serrated polyps, he/she was classified as an adenoma case: tubular adenoma, tubulovillous adenoma, or villous adenoma. Cases with hyperplastic polyps, traditional serrated adenomas, or SSPs and no adenomas were classified as serrated polyp cases (31) . SSPs were distinguished from other serrated polyps if they displayed exaggerated crypt serration, crypt dilatation, crypt branching, horizontal crypt extensions at the base, or other distortions of architectural organization and maturation that rendered them distinct from other serrated polyps (16) .
Classification of lesion severity
Adenomas were classified as advanced if they 1) were ≥10 mm in diameter according to the endoscopic determination of polyp size or 2) had ≥20% villous components or high-grade dysplasia according to the standard pathology review. Among serrated polyps, SSPs were considered advanced lesions. Notably, traditional serrated adenomas are also a distinct type of advanced serrated polyp; however, these were excluded from analyses of lesion severity because there were only 14 cases.
Classification of anatomical location
Anatomical location was abstracted from the electronic medical record. For site-specific analyses, proximal lesions were those proximal to the splenic flexure. Cases with one or more proximal polyps but no distal or rectal polyps were included in the proximal case group. Similarly, cases with one or more distal/rectal polyps but no proximal lesions were included in the distal/rectal case group.
Statistical analyses
Because we oversampled proximal cases to ensure adequate statistical power, all statistical analyses were weighted to reflect the distribution of polyps in the source population. Polytomous logistic regression was used to estimate adjusted odds ratios and 95% confidence intervals comparing each case group with the polyp-free control group (32) . These same models were used to compare case groups with one another, and the Wald P value for the comparison between case groups was calculated for each risk factor.
Adjustment variables and variables of interest were selected a priori on the basis of prior studies that found an association between each factor and colorectal neoplasia. All regression analyses were adjusted for study phase, age, sex, education, body mass index (BMI; weight (kg)/height (m) 2 ), regular NSAID use (2 or more doses per week for 12 continuous months, with current use defined as 1 year prior to index colonoscopy), family history of colorectal cancer (1 or more first-degree relatives with colorectal cancer), previous endoscopy (sigmoidoscopy or colonoscopy 2 or more years prior to the study colonoscopy), postmenopausal hormone use, cigarette smoking status, usual alcohol consumption, and recreational physical activity. Approximately 7% (n = 175) of study participants were missing data on one or more of these exposure variables and were excluded from the analyses. Study participants excluded from analyses on the basis of missing data were not significantly different from other study participants with respect to colorectal polyp status or other variables of interest. Variables were categorized as shown in Table 1 . All tables display weighted percentages and odds ratios but unweighted values for n. Weights were normalized to sum to the unweighted sample size. All statistical analyses were performed using SAS 9.2 (SAS Institute, Inc., Cary, North Carolina).
Exploratory analysis restricting the study population to participants without previous endoscopy was also conducted to determine whether the study results differed in this group.
RESULTS
Histological type
A total of 2,506 participants were included in analyses of risk factors by histological type, comprising 628 cases with adenomas only, 594 cases with serrated polyps only, 247 cases with synchronous adenomas and serrated polyps, and 1,037 colonoscopy-negative controls (Table 1) . Compared with controls, adenoma cases were more likely to be older and obese and were less likely to be women, to use NSAIDs regularly, to participate in recreational physical activity, and to have undergone prior endoscopy. Cases with serrated polyps were more likely than controls to be older, to have higher education, and to be current smokers and, among women, less likely than controls to have used estrogen-only hormone therapy. Patients with synchronous adenomas and serrated polyps had risk factor profiles similar to those of the adenoma-only cases but were more likely than controls to report a family history of colorectal cancer. Other risk factors in Table 1 were not statistically significantly associated with any of the polyp groups.
Of all the risk factors evaluated, only the associations for sex, ever use of estrogen-only postmenopausal hormone therapy, and smoking status were statistically significantly different between adenoma cases and serrated polyp cases (for sex and smoking status, P < 0.001; for estrogen-only postmenopausal hormone therapy, P = 0.01). Women had a 40% (95% confidence interval (CI): 21, 55) decrease in the odds of adenoma compared with men, but the odds of serrated polyps were not associated with sex (odds ratio (OR) = 1.06, 95% CI: 0.80, 1.40). Among women, serrated polyps were inversely associated with estrogen-only postmenopausal hormone therapy (OR = 0.63, 95% CI: 0.44, 0.90), but adenomas were not (OR = 1.09, 95% CI: 0.77, 1.55). Current cigarette smoking had a stronger association with serrated polyps (OR = 3.0, 95% CI: 1.93, 4.66) than with adenomas (OR = 1.56, 95% CI: 0.99, 2.44).
Lesion severity
Of the 628 adenoma cases, 175 had 1 or more advanced adenomas (including 40 patients with synchronous advanced and nonadvanced adenomas), 286 had only nonadvanced adenomas, and 167 were excluded because of missing polyp-size data. For serrated polyps, SSP histology was considered a marker of an advanced lesion. Of the 594 serrated polyp cases, 149 had 1 or more SSPs (including 42 patients with synchronous SSPs and non-SSP serrated polyps), 431 had only hyperplastic polyps (i.e., nonadvanced serrated polyps), and 14 had traditional serrated adenomas and were excluded ( Table 2) .
For most risk factors, the strength of the association did not vary significantly by lesion severity. However, for adenomas, older age (≥70 years vs. < 50 years) was positively associated with advanced adenoma (OR = 3.78, 95% CI: 1.62, 8.80) but not with nonadvanced adenoma (OR = 1.25, 95% CI: 0.77, 2.27) (for nonadvanced vs. advanced adenomas, P = 0.05), and prior endoscopy was associated with decreased odds of advanced adenoma (OR = 0.39, 95% CI: 0.27, 0.56) but not with nonadvanced adenoma (OR = 0.99, 95% CI: 0.74, 1.32) (for nonadvanced vs. advanced adenomas, P < 0.001). Of all exposures examined, only education was differently associated with SSPs compared with nonadvanced serrated polyps (P = 0.01).
Anatomical site
Analyses of risk factors by anatomical site included 212 cases with ≥1 proximal adenomas, 323 cases with ≥1 distal adenomas, 199 cases with ≥1 proximal serrated polyps, and 322 cases with ≥1 distal/rectal serrated polyps. Cases with both proximal and distal/rectal lesions and those missing information on polyp site were excluded from the site-specific analyses (n = 93 adenomas and n = 73 hyperplastic polyps) ( Table 3) .
For adenomas, only ever use of estrogen-only postmenopausal hormone therapy and smoking status had statistically significantly different associations between anatomical sites. Among women, ever use of estrogen-only postmenopausal hormone therapy was associated with an increased prevalence of adenomas in the proximal colon (OR = 1.68, 95% CI: 1.05, 2.71) but a statistically nonsignificant decrease in the prevalence of adenomas in the distal colon/rectum (OR = 0.78, 95% CI: 0.48, 1.27). Current smoking status was associated with increased odds of adenoma in the distal colon and rectum (OR = 2.19, 95% CI: 1.26, 3.78) but not in the proximal colon (OR = 0.83, 95% CI: 0.40, 1.73).
For serrated polyps, only BMI and smoking status had statistically significantly different associations between anatomical 
Exploratory analyses
Exploratory analyses restricted to persons without prior endoscopy produced point estimates similar to those of the unrestricted analyses (data not shown). However, the association between advanced adenoma and increasing age was stronger in the analyses restricted to participants without prior endoscopy.
DISCUSSION
Our results suggest that although adenomas and serrated polyps share many risk factors, there are some clear differences in the factors associated with these distinct groups. In addition, differences according to anatomical site and lesion severity were apparent. Factors for which the strength of the association varied statistically significantly between adenomas and serrated polyps were sex, use of estrogen-only postmenopausal hormone therapy, and smoking status. For adenomas, associations with age and with prior endoscopy varied by lesion severity, and associations with use of estrogen-only postmenopausal hormone therapy and with smoking status varied by anatomical site. For serrated polyps, the association with education varied by lesion severity, and the associations with BMI and with smoking status varied by anatomical site. Each risk factor for which differences between polyp subtypes were observed is discussed briefly below.
Sex
Prior study results vary with respect to sex differences between cases with adenomas and cases with serrated polyps. Some studies evaluating both polyp types found that, compared with women, men had higher risks of adenomas and of serrated polyps (15, 21, 33) ; other studies observed higher risks of adenomas in men than in women Abbreviations: BMI, body mass index; CI, confidence interval; NSAID, nonsteroidal antiinflammatory drug; OR, odds ratio. a Analyses by anatomical site excluded cases with synchronous adenomas and serrated polyps (n = 247), cases with both proximal and distal/rectal lesions, and cases with missing information on anatomical subsite (n = 93 adenomas and n = 73 hyperplastic polyps).
b Mutually adjusted for study phase and all other factors in the and no association between sex and serrated polyps (22, 23) , similar to our findings. Sex differences between polyp types could be mediated by hormones or by differences between men and women in the distribution of unknown, pathway-specific colorectal cancer risk factors.
Estrogen-only postmenopausal hormone therapy
The inverse association between postmenopausal hormone therapy and colorectal cancer is well-documented (34) (35) (36) (37) , but the link between colorectal polyps and hormone therapy is less clear. Similar to our results, results from the Polyp Prevention Trial suggested that the association between polyps and postmenopausal hormone therapy varied according to anatomical site; distal adenomas were associated with a decreased risk (OR = 0.56, 95% CI: 0.32, 1.00), and proximal adenomas were associated with a statistically nonsignificant increased risk (OR = 1.39, 95% CI: 0.85, 2.26) (38) . In a separate study population, Morimoto et al. (15) evaluated adenomas and hyperplastic polyps and reported a 30% decrease in the odds of hyperplastic polyps and a 50% decrease in the odds of adenomas associated with postmenopausal hormone therapy; associations by site were not reported. Our results suggest that the association between colorectal polyps and postmenopausal hormone therapy depends on polyp type and polyp location. Furthermore, results from a recent study suggest heterogeneity in the association between postmenopausal hormone use and colorectal cancer according to molecular tumor characteristics (39) . These findings warrant further investigation and may provide insight into the mechanisms by which estrogen may inhibit colorectal cancer.
Cigarette smoking
The finding that cigarette smoking has a stronger association with serrated polyps than it does with adenomatous polyps is supported by several prior studies (15, (20) (21) (22) 40) and was reinforced in the present study. Furthermore, colorectal cancer analyses suggest that the carcinomas most likely to arise from the serrated pathway-that is, cancers that are BRAF-mutated, CIMP-high, and MSI-high-are specifically associated with cigarette smoking (41) (42) (43) . These cancers occur most often in the proximal colon (44, 45 ), yet our results suggest a stronger association between distal/ rectal colorectal polyps and cigarette smoking. Several other studies, including a meta-analysis of the association between colorectal cancer and cigarette smoking, also suggest a specific association with distal/rectal neoplasia (33, 46, 47) . However, in the Iowa Women's Health Study, a large cohort study of over 37,000 women, Limsui et al. (43) recently reported an association between proximal colon cancer and cigarette smoking. Further research is needed to determine mechanisms by which cigarette smoking plays a role in the serrated pathway and to explore site-specific associations.
Age
The risk of colorectal cancer increases with increasing age, peaking between ages 60 and 79 years (48) . Therefore, it is not surprising that our results suggested that older age has a stronger association with advanced adenomas than with nonadvanced adenomas. However, the age distribution of people with adenomas was not statistically significantly different from the age distribution of those with serrated polyps. This is in contrast to prior studies suggesting that people with adenomas tend to be older than those with serrated polyps (15, 33) .
Prior endoscopy
Colorectal screening endoscopy is associated with a decreased risk of colorectal cancer incidence and mortality (49) (50) (51) (52) (53) (54) . During endoscopy, detection and removal of adenomas, particularly advanced adenomas, can avert progression to malignant disease (55) . Because most serrated polyps, including hyperplastic polyps and SSPs, were traditionally not considered targets of screening endoscopies, identification of these polyps would not have prompted changes in patient management or increased colorectal cancer surveillance. Therefore, our results indicating that prior endoscopy is associated with decreased odds of specifically advanced adenomas may be a consequence of screening guidelines that target polyps in the adenoma-carcinoma pathway (56) .
Education
Our results suggest that increasing education was associated with increased odds of SSPs, but there was no association between education and other polyps. This was an unexpected finding. Prior studies of colon neoplasia and indicators of socioeconomic status are mixed. Generally, studies of European populations report a positive (57) (58) (59) (60) or null (61) association between increasing socioeconomic status and colon cancer risk. However, recent studies of North American populations have tended to find inverse associations between colon cancer and increasing socioeconomic status, potentially mediated by differences in screening (62) (63) (64) . If the positive association between SSPs and increasing education is replicated, future studies should evaluate whether there is differential detection of SSPs among persons with higher educational levels because of better compliance with bowel preparation procedures, or whether lifestyle factors associated with high socioeconomic status are important to the etiology and progression of lesions in the serrated pathway.
Body mass index
A recent meta-analysis of the association between colorectal cancer and BMI suggested an increase in the risk of colorectal cancer with increasing BMI (65) . Studies of adenomas also tend to support a positive association between risk of colorectal neoplasia and increasing BMI (66) (67) (68) (69) . However, the association between serrated polyps and BMI is less clear, with some studies suggesting a positive association (26, 70) and others finding no statistically significant association between serrated polyps and BMI (71, 72) . Furthermore, prior studies suggest that sex may modify the association between colorectal neoplasia and BMI (15, 65, 73) .
Additionally, the association may vary by anatomical site (65) . With results similar to ours, Wallace et al. (70) reported that BMI was associated with an increased risk of serrated polyps specifically in the distal colon and rectum. The association between BMI and colorectal neoplasia is complex, and further investigation is needed to determine the role of BMI in the serrated pathway.
Risk factors for synchronous adenomas and serrated polyps
Patients with synchronous adenomas and serrated polyps had stronger associations with age, obesity, NSAID use, and family history of colorectal cancer than those with only 1 type of polyp. Because these are all well-established factors associated with colorectal cancer risk (35) , it may be that persons with both types of polyps represent a highrisk group for the development of colorectal cancer. This thesis is supported by prior studies (74, 75) . Additional longitudinal studies are needed to determine whether persons with synchronous adenomas and serrated polyps are at high risk for the development of advanced colorectal neoplasia.
Limitations
To our knowledge, this is the largest and most comprehensive study to have evaluated differences in risk factors between distinct colorectal polyp subgroups. Although we included a large number of participants, the necessity of classifying cases according to multiple features resulted in smaller subgroups for analyses and may have reduced our power to detect associations. At the same time, the large number of comparisons made in our analysis may have resulted in some spurious associations. Despite these statistical challenges, the ability to connect risk factors to specific subsets of polyps can provide insight into mechanisms for cancer initiation and progression in different carcinogenic pathways. In addition, our study results may have been subject to differential recall bias; however, for case-case comparisons of polyp subtypes, recall-related misclassification of exposures would likely have been nondifferential (76) . We also did not have detailed information on prior colorectal polyp diagnoses. If prior polyps were removed during an earlier endoscopy, odds ratio estimates may have been attenuated; however, exploratory analyses restricted to persons without prior endoscopy produced findings similar to those of the unrestricted analyses. Finally, serrated polyps, particularly SSPs, are difficult to visualize, and it is likely that serrated polyps were missed in some controls and other polyp cases (77) . This would have resulted in bias towards the null, so reported associations for serrated polyps may be conservative.
Conclusions
Overall, the results of our study further illustrate the heterogeneous nature of colorectal cancer and its precursor lesions. Furthermore, our analyses of SSPs suggest that these newly characterized lesions have a strong association with smoking, similar to hyperplastic polyps, and that SSPs may also be associated with higher levels of education. By connecting risk factors with specific subgroups of polyps, our results may help identify high-risk groups for colorectal cancer surveillance and open new avenues for understanding mechanisms that are unique to different colorectal cancer pathways.
